tradingkey.logo
tradingkey.logo
Suchen

Gelteq Ltd

GELS
Zur Watchlist hinzufügen
0.580USD
-0.080-12.17%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
6.21MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Gelteq Ltd Unternehmen

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Gelteq Ltd Informationen

BörsenkürzelGELS
Name des UnternehmensGelteq Ltd
IPO-datumOct 29, 2024
CEOGivoni (Nathan Jacob)
Anzahl der mitarbeiter7
WertpapierartOrdinary Share
GeschäftsjahresendeOct 29
AddresseLevel 4
StadtMELBOURNE
BörseNASDAQ OMX - NASDAQ BASIC
LandAustralia
Postleitzahl3205
Telefon61390873990
Websitehttps://www.gelteq.com
BörsenkürzelGELS
IPO-datumOct 29, 2024
CEOGivoni (Nathan Jacob)

Führungskräfte von Gelteq Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Gelteq Ltd?

Die fünf größten Anteilseigner von Gelteq Ltd sind: Mr. Nathan Jacob Givoni

Wie viele Institutionen halten Anteile an Gelteq Ltd (GELS)?

Mit Stand vom 2026Q1 halten 9 Institutionen Anteile an Gelteq Ltd, mit einem Gesamtmarktwert von etwa 87.15K, was 0.81% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -29363.00 gestiegen.